Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
3192 |
|
| Actual shortage: | 255 (8%) | |
| Anticipated shortage: | 1 (0%) | |
| Avoided shortage: | 10 (0%) | |
| Resolved: | 2926 (92%) | |
Discontinuation Reports |
435 |
|
| To be discontinued: | 2 (0%) | |
| Discontinued: | 410 (94%) | |
| Reversed: | 23 (5%) | |
Late reports |
482 (13%) |
|
Overdue reports |
11 (4%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-SOLIFENACIN | 5MG | TABLET | Resolved | 2023-06-19 | 2024-06-07 | 195652 |
| TEVA-SOLIFENACIN | 10MG | TABLET | Resolved | 2024-08-30 | 2025-09-11 | 236376 |
| TEVA-SOLIFENACIN | 10MG | TABLET | Resolved | 2024-09-05 | 2025-01-23 | 236819 |
| TEVA-SPIRONOLACTONE | 100MG | TABLET | Resolved | 2017-03-13 | 2020-02-13 | 1560 |
| TEVA-SPIRONOLACTONE | 25MG | TABLET | Resolved | 2017-03-13 | 2017-10-11 | 1568 |
| TEVA-SPIRONOLACTONE | 100MG | TABLET | Resolved | 2017-08-02 | 2018-02-21 | 18025 |
| TEVA-SPIRONOLACTONE | 25MG | TABLET | Resolved | 2018-03-13 | 2018-05-30 | 42604 |
| TEVA-SPIRONOLACTONE | 25MG | TABLET | Resolved | 2020-03-06 | 2020-03-26 | 107970 |
| TEVA-SPIRONOLACTONE | 100MG | TABLET | Resolved | 2020-04-23 | 2020-05-08 | 113016 |
| TEVA-SPIRONOLACTONE | 100MG | TABLET | Resolved | 2020-07-16 | 2020-11-07 | 120488 |
| TEVA-SPIRONOLACTONE | 25MG | TABLET | Resolved | 2020-08-13 | 2020-11-07 | 122217 |
| TEVA-SPIRONOLACTONE | 25MG | TABLET | Resolved | 2020-11-12 | 2021-01-28 | 128339 |
| TEVA-SPIRONOLACTONE | 25MG | TABLET | Resolved | 2020-12-17 | 2021-01-21 | 130296 |
| TEVA-SPIRONOLACTONE | 25MG | TABLET | Resolved | 2021-02-25 | 2021-05-06 | 134749 |
| TEVA-SPIRONOLACTONE | 100MG | TABLET | Resolved | 2021-03-18 | 2021-05-06 | 135949 |
| TEVA-SPIRONOLACTONE | 25MG | TABLET | Resolved | 2022-08-18 | 2023-04-28 | 167212 |
| TEVA-SPIRONOLACTONE | 100MG | TABLET | Resolved | 2022-08-18 | 2022-12-15 | 167255 |
| TEVA-SPIRONOLACTONE | 100MG | TABLET | Resolved | 2023-06-08 | 2023-07-05 | 194071 |
| TEVA-SPIRONOLACTONE | 100MG | TABLET | Resolved | 2023-06-16 | 2023-07-12 | 195225 |
| TEVA-SPIRONOLACTONE | 100MG | TABLET | Resolved | 2025-02-13 | 2025-04-10 | 250384 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-FUROSEMIDE | 20MG | TABLET | Discontinued | 2017-06-27 | 2017-06-27 | 14039 |
| TEVA-FUROSEMIDE | 40MG | TABLET | Discontinued | 2017-06-27 | 2017-06-27 | 14042 |
| TEVA-GLYBURIDE | 2.5MG | TABLET | Discontinued | 2025-05-28 | 2025-05-28 | 258547 |
| TEVA-HALOPERIDOL | 20MG | TABLET | Discontinued | 2019-10-25 | 2019-10-26 | 97270 |
| TEVA-HYDROCHLOROTHIAZIDE | 50MG | TABLET | Discontinued | 2025-05-28 | 2025-05-28 | 258383 |
| TEVA-HYDROMORPHONE | 1MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64970 |
| TEVA-HYDROMORPHONE | 2MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64975 |
| TEVA-HYDROMORPHONE | 4MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64983 |
| TEVA-HYDROMORPHONE | 8MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64993 |
| TEVA-HYDROMORPHONE | 1MG | TABLET | Discontinued | 2020-02-13 | 2020-02-13 | 106158 |
| TEVA-HYDROMORPHONE | 2MG | TABLET | Discontinued | 2020-02-13 | 2020-02-13 | 106161 |
| TEVA-HYDROMORPHONE | 4MG | TABLET | Discontinued | 2020-02-13 | 2020-02-13 | 106164 |
| TEVA-HYDROMORPHONE | 8MG | TABLET | Discontinued | 2020-02-13 | 2020-02-13 | 106167 |
| TEVA-IRBESARTAN | 75MG | TABLET | Discontinued | 2024-04-01 | 2024-04-01 | 224049 |
| TEVA-IRBESARTAN | 150MG | TABLET | Discontinued | 2025-06-17 | 2025-06-17 | 260527 |
| TEVA-IRBESARTAN | 300MG | TABLET TABLET | Discontinued | 2025-06-17 | 2025-06-17 | 260546 |
| TEVA-IRBESARTAN HCTZ | 300MG 12.5MG | TABLET | Discontinued | 2024-06-28 | 2024-06-29 | 231577 |
| TEVA-IRBESARTAN HCTZ | 300MG 25MG | TABLET | Discontinued | 2024-06-28 | 2024-06-29 | 231580 |
| TEVA-IRBESARTAN HCTZ | 150MG 12.5MG | TABLET | Discontinued | 2025-06-17 | 2025-06-17 | 260549 |
| TEVA-LAMIVUDINE/ZIDOVUDINE | 300MG 150MG | TABLET | Discontinued | 2020-01-24 | 2020-01-24 | 104260 |